Human monkeypox virus: A systematic critical review during the pandemic peak

IF 1.4 4区医学 Q4 IMMUNOLOGY Indian Journal of Medical Microbiology Pub Date : 2024-08-14 DOI:10.1016/j.ijmmb.2024.100704

Neama Derhab

{"title":"Human monkeypox virus: A systematic critical review during the pandemic peak","authors":"Neama Derhab","doi":"10.1016/j.ijmmb.2024.100704","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>In July 2022, the world health organization (WHO) announced the monkeypox virus (MPXV) as a public health emergency of international concern, due to the unprecedented global transmission of the disease beyond previously endemic countries in Africa.</p></div><div><h3>Methods</h3><p>For this systematic review, the author searched the “web of science” (WoS) database, which retrieves 138 articles on MPXV, published between 01-04–2022 and 22-09-2022. This period witnessed the maximum cases of infection as confirmed by the WHO. Seventy articles were used for in-depth analysis, after excluding papers not highly relevant to the topic.</p></div><div><h3>Results and conclusions</h3><p>The current review demonstrates different types of MPXV identification analysis, transmission of MPXV, clinical features, immune responses against MPXV, the mutations, and phylogenetic analysis. It also identifies the patients with high-risk complications and determines the other diseases related to MPXV. This paper provides suggestions for the suitable usage of vaccines or antiviral drugs as a procedure to control the outbreak and preventive strategies related to the humans. This research discusses significant implications and recommendations to contribute in reducing the spread of MPXV and presents avenues for upcoming MPXV research.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"51 ","pages":"Article 100704"},"PeriodicalIF":1.4000,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Medical Microbiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0255085724001798","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

In July 2022, the world health organization (WHO) announced the monkeypox virus (MPXV) as a public health emergency of international concern, due to the unprecedented global transmission of the disease beyond previously endemic countries in Africa.

Methods

For this systematic review, the author searched the “web of science” (WoS) database, which retrieves 138 articles on MPXV, published between 01-04–2022 and 22-09-2022. This period witnessed the maximum cases of infection as confirmed by the WHO. Seventy articles were used for in-depth analysis, after excluding papers not highly relevant to the topic.

Results and conclusions

The current review demonstrates different types of MPXV identification analysis, transmission of MPXV, clinical features, immune responses against MPXV, the mutations, and phylogenetic analysis. It also identifies the patients with high-risk complications and determines the other diseases related to MPXV. This paper provides suggestions for the suitable usage of vaccines or antiviral drugs as a procedure to control the outbreak and preventive strategies related to the humans. This research discusses significant implications and recommendations to contribute in reducing the spread of MPXV and presents avenues for upcoming MPXV research.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

人类猴痘病毒：大流行高峰期的系统性关键审查。

背景：2022年7月，世界卫生组织（WHO）宣布猴痘病毒（MPXV）为国际关注的突发公共卫生事件，原因是该疾病在非洲以前流行的国家之外出现了前所未有的全球传播：作者在 "web of science"（WoS）数据库中检索了 138 篇关于 MPXV 的文章，这些文章发表于 2022 年 4 月 1 日至 2022 年 9 月 22 日之间。这一时期是世卫组织确认的感染病例最多的时期。在剔除了与该主题不太相关的文章后，有 70 篇文章被用于深入分析：本综述展示了不同类型的 MPXV 鉴定分析、MPXV 传播、临床特征、针对 MPXV 的免疫反应、突变和系统发育分析。它还识别了高危并发症患者，并确定了与 MPXV 相关的其他疾病。本文就适当使用疫苗或抗病毒药物作为控制疫情的程序以及与人类相关的预防策略提出了建议。本研究讨论了有助于减少 MPXV 传播的重要意义和建议，并为即将开展的 MPXV 研究提供了途径。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Indian Journal of Medical Microbiology IMMUNOLOGY-

CiteScore

2.20

自引率

0.00%

发文量

154

审稿时长

73 days

期刊介绍： Manuscripts of high standard in the form of original research, multicentric studies, meta analysis, are accepted. Current reports can be submitted as brief communications. Case reports must include review of current literature, clinical details, outcome and follow up. Letters to the editor must be a comment on or pertain to a manuscript already published in the IJMM or in relation to preliminary communication of a larger study. Review articles, Special Articles or Guest Editorials are accepted on invitation.